中国生物制药(01177)公布，集团开发的"TQC3721(PDE3/4抑制剂)"、"TQC2731(TSLP单 抗)"、"TQC3403(乌美溴铵维兰特罗吸入粉雾剂)"将于9月27日至10月1日举行的2025年欧洲呼吸学会年 会(ERS2025)公布4项研究成果。 ...

Core Insights - China Biopharmaceutical (01177) announced the presentation of four research results for its developed products at the 2025 European Respiratory Society Annual Meeting (ERS 2025) scheduled from September 27 to October 1 [1] Group 1 - The products to be presented include "TQC3721 (PDE3/4 inhibitor)", "TQC2731 (TSLP monoclonal antibody)", and "TQC3403 (Umeclidinium/Vilanterol inhalation powder)" [1]

智通财经APP讯，中国生物制药(01177)公布，集团开发的"TQC3721 (PDE3/4抑制剂)"、"TQC2731 (TSLP单抗)"、"TQC3403 (乌美溴铵维兰特罗吸入粉雾剂)"将于9月27日至10月1日举行的2025年欧洲呼 吸学会年会 (ERS 2025)公布4项研究成果。 ...